Search

Contributor:

and Glenn J. Jaffe, MD

Late-Breaking Phase 3 Data From AAO Retina Subspecialty Day

AAO 2021: Updates in Uveitis and Trauma

Late-Breaking Phase 3 Data From AAO Retina Subspecialty Day

Glenn Jaffe, MD; and Rahul Khurana, MD

20th Duke Advanced Vitreous Surgery Course

20th Duke Advanced Vitreous Surgery Course

Cynthia A. Toth, MD, Glenn Jaffe, MD, Tamer Mahmoud, MD, PhD

Intraocular Sustained Drug Delivery in 2019

Intraocular Sustained Drug Delivery in 2019

Glenn Jaffe, MD

Founders Lecture: Intraocular Sustained Drug Delivery

Founders Lecture: Intraocular Sustained Drug Delivery

Glenn Jaffe, MD, Timothy Murray, MD, MBA

Imaging and Uveitis: How to Apply Imaging Information

Imaging and Uveitis: How to Apply Imaging Information

Glenn Jaffe, MD, Tim Murray, MD

Clinical Trials Evaluating IONIS-FB-Lrx

Clinical Trials Evaluating IONIS-FB-Lrx

Glenn Jaffe, MD

Diabetic Surgery: The Basics

Diabetic Surgery: The Basics

Lisa C. Olmos de Koo, MD, MBA; and Glenn J. Jaffe, MD

Promising Anatomic Outcomes from LIGHTSITE III Trial

Promising Anatomic Outcomes from LIGHTSITE III Trial

Diana V. Do, MD, and Glenn J. Jaffe, MD

Valeda Demonstrates Vision Improvement in Patients with Dry AMD

Valeda Demonstrates Vision Improvement in Patients with Dry AMD

Diana V. Do, MD, and Glenn J. Jaffe, MD

AI in Clinical Trials: Where We Are Now

AI in Clinical Trials: Where We Are Now

Glenn J. Jaffe, MD; and Michael J. Allingham, MD, PhD

AAO 2021: Updates in Uveitis and Trauma

Glenn Jaffe, MD; and Nicole Koulisis, MD

Duke AVS Clips: Pediatrics, Anesthesia Trends, and AI

Lejla Vajzovic, MD; Jason Fan, MD; Glen J. Jaffe, MD